Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00580814 · ClinicalTrials.gov registry record · NA

Brain Dopamine Function in Adults With ADHD

A NA study, sponsored by University of California, Irvine.

Completed
Registry status
NA
Development phase
75
Enrollment target

NCT00580814: Completed NA study, sponsored by University of California, Irvine.

NCT00580814 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 75 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00580814, a NA study, has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target

Study Summary

The purpose of the study is to investigate the functional state of dopamine cells and the dopamine transporter in ADHD subjects and controls to assess the effects of chronic methylphenidate treatment on dopamine cell function and dopamine transporter levels in ADHD subjects.

Primary Outcome

Striatal DAT availability as noted in PET scans post one year of methylphenidate treatment or no intervention. The unit listed as binding potential (BPND) was measured with a dynamic PET scan protocol, using carbon-11 labeled cocaine, a radioligand with specific binding to DAT (which is inhibited by drugs that block DAT but not by drugs that block the norephephrine or serotonin transporters). This radiotracer was utilized to quantify DAT availability as non-displaceable binding potential using

Interventions

  • DRUG Experimental: methylphenidate treatment

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2006-02
Est. Completion 2009-04
Phase NA
University of California, Irvine

368 total trials

What the finished NCT00580814 record still lists

NCT00580814 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Experimental: methylphenidate treatment is the first listed.

NCT00580814 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00580814 about?

NCT00580814 is a clinical study titled "Brain Dopamine Function in Adults With ADHD". The purpose of the study is to investigate the functional state of dopamine cells and the dopamine transporter in ADHD subjects and controls to assess the effects of chronic methylphenidate treatment on dopamine cell function and dopamine transporter levels in ADHD subjects.

What is the current status of trial NCT00580814?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2006-02. Estimated completion is 2009-04.

What interventions are being tested in trial NCT00580814?

The interventions under investigation include: Experimental: methylphenidate treatment (DRUG).

Who is sponsoring clinical trial NCT00580814?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00580814's enrollment target sits among peer trials

75 1069th of 2000 higher than 919 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00580814, the US trial registry maintained by the National Library of Medicine. NCT00580814 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.